A freelance writer and traveller who likes to explore the spiritual, literary and hidden gems of Adelaide and beyond.
A Research Trial Monitoring Sleep Apnoea
Sleep is a poorly understood phenomenon that impacts very much on our well being. The consequences of sleep loss are under appreciated and unrecognised. Workplaces and much of the community are slowly becoming more aware of the impact of poor sleep quality. Those who have a healthy sleep pattern are in general happier, healthier and more productive.
Poor sleep quality has been linked to obesity and adversely affects alertness, thinking, productivity, mood, safety and learning. In general we function a lot worse on a poor night's sleep. It can also affect our mental health and cardiovascular system.
Research is currently being undertaken in those people who have been diagnosed with obstructive sleep apnoea, mainly when asleep on their back, for a trial of a new device which prevents supine sleep (sleeping on your back). Potential participants must not have previously used BuzzPOD treatment, or continuous airway pressure (CPAP) treatment for more than one week.
Sleep apnoea is a type of sleep disorder characterized by pauses in breathing or instances of shallow or infrequent breathing during sleep. The trial is being run by the Adelaide Institute for Sleep Health located at Repatriation General Hospital in Daw Park. The sleep study involves an 8-week program of continuous airway pressure (CPAP) treatment and 8 weeks of supine-avoidance therapy (using BuzzPOD Monitor) in a randomly allocated treatment order.
BuzzPOD is a small position recording and supine alarm device. Worn on the chest during sleep. BuzzPOD monitors the sleeping position and encourages users to avoid sleeping on their back by vibrating if the user remains on their back for longer than five seconds.
The research trial is undertaken in conjunction with a sleep physician, who will discuss treatment options following the trial.
The research team are recruiting now for this study. Want to find out more? More information is available via the trial co-ordinator Melanie Heath. Melanie can be contacted at email@example.com or 8275 1322.